PepGen Inc.

PEPG chart

PepGen Inc. news

• Form 424B5 PepGen Ltd For: 11 November By Investing.com

  Investing.com Canada · Nov 11, 1:07 AM EST

• PepGen's Myotonic Dystrophy Drug Sets Phase 2 Efficacy Record: FDA Hold Still Bars American Patients

  Tech Times · Nov 10, 8:04 PM EST

• PepGen’s DM1 readout hints at functional payoff from splicing correction

  BioCentury · Nov 10, 7:29 PM EST

• PepGen (PEPG) Launches $125M Public Offering to Fund Clinical Tr

  GuruFocus · Nov 10, 6:26 PM EST

• PepGen Launches $125 Million Stock Offering

  marketscreener.com · Nov 10, 5:34 PM EST

• PepGen launches $125 million public stock offering

  Investing.com · Nov 10, 4:58 PM EST

• PepGen launches $125M public stock offering

  StreetInsider · Nov 10, 4:51 PM EST

• PepGen soars on promising early data for muscular dystrophy drug

  biopharmadive.com · Nov 10, 4:48 PM EST

• PepGen launches $125M stock offering to support clinical development

  TradingView · Nov 10, 4:46 PM EST

• PepGen Announces Proposed $125.0 Million Public Offering of Common Stock

  Yahoo Finance · Nov 10, 4:23 PM EST

• PepGen Inc. (PEPG) Misses Q3 EPS by 1c

  StreetInsider · Nov 10, 4:14 PM EST

• BofA Securities Upgrades PepGen Inc. (PEPG) to Neutral

  StreetInsider · Nov 10, 3:52 PM EST

PepGen Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-11-10
• 10-Q10-Q2026-11-10
• 8-K8-K2026-08-06
• 10-Q10-Q2026-08-06
• 8-K8-K2026-06-22
• 8-K8-K2026-05-21
• 8-K8-K2026-05-12
• 10-Q10-Q2026-05-12
• DEF 14ADEF 14A2026-04-28
• 8-K8-K2026-03-30
• 8-K8-K2026-03-04
• 10-K10-K2026-03-04

About PepGen Inc.

Ticker

PEPG (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Boston, MA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1835597

Frequently asked questions